Novotech said that Siebel Clinical Trial Management System met the organisation’s present needs, and is built on open standards allowing the company to integrate other business applications, such as its financial system.
Siebel Clinical Trial Management System will also serve as a centralised repository for all investigators to collect and track relevant information about research, including personal profiles to disease specialities.
The system will offer a consistent view of the clinical trials undertaken by Novotech and provide up to date information on clinical trial statuses across the organisation.
Furthermore, it will provide a common platform that will assist Novotech to conduct its activities to achieve operational efficiencies.
In addition to managing the trial management process, Siebel Clinical Trial Management System will assist to provide timely and accurate reports and dashboards to support tactical and strategic decision making.
Novotech expects to see improved process efficiencies, better trial quality and lower trial costs from the implementation and also planning to integrate the system with Novotech’s finance system.
Novotech Australia CEO Alek Safarian said that as they continue to expand, they need a system that can grow with business operations and support ability to run successful clinical trials across the globe. Novotech’s investment in this field with industry leading technology systems like Oracle’s Siebel Clinical Trial Management System showcases the efforts to be recognised as a world-class CRO.